$HSKA

Heska Corp.

  • NASDAQ
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$101.03 -

Extented Hours

VOLUME

71,909

DAY RANGE

94.99 - 101.71

52 WEEK

82.92 - 275.94

Join Discuss about HSKA with like-minded investors

profile
@dros #droscrew
recently

Upgrades 7/12: $AMG $CAKE $CVET $EAT $FTV $GBX $HSKA $IR $IVZ $MFC $PK $RGA $RHP $TRV $TSC  . Downgrades 7/12: $APAM $CHTR $CLOV $ESRT $IDXX $MMM $RKT $STMP $SWAV $UAL $WSO

145 Replies 15 👍 15 🔥

profile
@dros #droscrew
recently

+Initiations 1/29: $AIRC $AMRC $AWH $BLU $HSKA $ICAD $IDXX $IGMS $LSCC $NMTR $PAGS $PEIX $RSI $STNE $VIVE $XL $XPEV . -Initiations 1/29: $RLGY

43 Replies 10 👍 8 🔥

Key Metrics

Market Cap

1.09 B

Beta

1.08

Avg. Volume

110.85 K

Shares Outstanding

10.79 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-02

Next Dividend Date

Company Information

Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

CEO: Kevin Wilson

Website:

HQ: 3760 Rocky Mountain Ave Loveland, 80538-7084 Colorado

Related News